|
07 Oct 2025 |
Ambuja Cements
|
Consensus Share Price Target
|
573.80 |
654.18 |
- |
14.01 |
buy
|
|
|
|
|
18 Feb 2019
|
Ambuja Cements
|
Prabhudas Lilladhar
|
573.80
|
205.00
|
197.60
(190.38%)
|
Target met |
Hold
|
|
|
Ambuja Cement (ACEM) reported disappointing set of Q4CY18 earnings with Change in Estimates | Target | Reco miss across the fronts. EBITDA/t fell to multi-quarter low of Rs500 (PLe:Rs725) due to steep increase in costs and weak realisations. Lumpiness...
|
|
29 Oct 2018
|
Ambuja Cements
|
Religare
|
573.80
|
247.00
|
192.55
(198.00%)
|
|
Buy
|
|
|
Ambuja Cements Ltd (ACL) reported subdued numbers for Q3CY18. While revenue growth at 12.7% YoY was in line with our estimates, the company disappointed on the profit front with a marginal 1.1% growth in EBITDA and 34.4% YoY decline in PAT. EBITDA margins contracted 158bps YoY to 13.7%, impacted by higher power & fuel and freight cost.
|
|
25 Oct 2018
|
Ambuja Cements
|
ICICI Securities Limited
|
573.80
|
231.00
|
192.35
(198.31%)
|
Target met |
Buy
|
|
|
Ambuja's results were above our estimates on revenue terms but a miss on the margins and PAT front. Revenues increased 12.7% YoY (up 13.4% QoQ) to |2,614 crore (above I-direct estimate of |2530 crore) led by 9% YoY increase in volumes to 5.46 MT(vs I-direct estimate of 5.5 MT) and 3.6% YoY increase in realisation to | 4,787 (vs I-direct estimate of |4,600/t. EBITDA margin decreased 158bps YoY to 13.7% (vs I-direct est: 15.2%) mainly led by 13.1% YoY increase in power cost (led by...
|
|
24 Oct 2018
|
Ambuja Cements
|
IDBI Capital
|
573.80
|
207.00
|
195.00
(194.26%)
|
Target met |
Accumulate
|
|
|
Ambuja's Q3CY18 sales was better than our estimate, however, profitability was disappointing. Sales grew by 12.6% YoY to Rs26,139 mn mainly led by higher cement volumes at 5.54 mn tonnes (+8.8% YoY). Realization also increased marginally by 3.5% YoY to Rs4,787/tonne. However, EBITDA margin was below our forecast by 402bps mainly on higher than expected energy and freight expenses. EBITDA margin contracted 156bps YoY to 13.7%. Net profit fell by 34.4% YoY to Rs1,786 mn vs. our...
|
|
24 Oct 2018
|
Ambuja Cements
|
Dolat Capital
|
573.80
|
229.00
|
192.35
(198.31%)
|
Target met |
Buy
|
|
|
Ambuja Cements
Lower than expected volume & realisation growth coupled with sharp increase in cost/tonne resulted in ACEM reporting weaker than expected performance. ACEM reported net income of ` 26.1bn (+12.6% YoY, -13.4% QoQ), 5.5% lower than D'est. Realisation at ` 4,787/tonne (+3.5% YoY, +1.1% QoQ). Cement despatches at 5.46 MnT (+8.8% YoY, -14.3% QoQ)....
|
|
23 Oct 2018
|
Ambuja Cements
|
Reliance Securities
|
573.80
|
235.00
|
201.05
(185.40%)
|
Target met |
Buy
|
|
|
Sales volume grew by 9% YoY to 5.5mnT (at a base of 10% YoY growth in 3QCY17), led by sustained demand environment in its key markets. Revenue grew by ~11% YoY to Rs25.2bn led by robust volume growth. Notably, sales volume grew by 5.8% YoY to 18.1mnT in 9MCY18....
|
|
23 Oct 2018
|
Ambuja Cements
|
Centrum Broking
|
573.80
|
230.00
|
192.35
(198.31%)
|
Target met |
Buy
|
|
|
Ambuja Cements
We upgrade ACEM to BUY with unchanged TP of Rs230, as the recent stock price corrections has turned valuations attractive the stock is trading at 10.6x/9.4x its CY19/20E EBITDA. During Q3CY18, ACEM's standalone EBITDA rose a modest 5% YoY, as the strong 9% YoY volume growth benefits were moderated by high cost pressure. PAT declined 32% YoY on absence of dividend income from its subsidiary ACC, during the quarter. We model in 5% volume CAGR for CY17-20E amid no near term capacity expansion. The material supply agreement (MSA) with ACC should partly moderate the cost inflation going forward, thus aiding 9% EBITDA CAGR during CY17-20E....
|
|
23 Oct 2018
|
Ambuja Cements
|
JM Financial
|
573.80
|
|
192.35
(198.31%)
|
|
Hold
|
|
|
Ambuja Cements
Ambuja Cement (Ambuja)'s 3QCY18 EBITDA missed the expectations primarily on higher other expenses. Revenues rose 13% YoY on volume growth of 9%. Realisations improved by 3.6% on a YoY basis; sequential growth of 1%. EBITDA grew by 15.6% on a YoY basis. EBITDA/t was reported at INR 648/t (vs. INR 609/t in 3QCY17), grew as realisation improvement and lower other expenses was partially offset by increase in operating costs. We believe Ambuja's long-term growth is constrained by its clinker capacity and limited expansion plans (phase 1 expansion of 1.7MTPA of clinker at Marwar Mundwa expected by 2HCY20). As a result, we expect Ambuja's market share to decline in the interim. While the...
|
|
23 Oct 2018
|
Ambuja Cements
|
Emkay
|
573.80
|
201.00
|
201.05
(185.40%)
|
Target met |
Accumulate
|
|
|
Ambuja Cements Q3 results were below our estimates with EBITDA at Rs3.6bn vs. our estimate of Rs4.4bn and OPM at 13.7% vs. our estimate of 17.5%. Opex/ton increased 9.9% qoq vs. our estimate of 6.4%. EBITDA/ton was Rs656 vs. our Rs737 estimate. Sales volumes were 5.46mt, up 8.5% yoy vs. our estimate of 7%. Capacity utilization was...
|
|
09 Oct 2018
|
Ambuja Cements
|
Religare
|
573.80
|
262.00
|
204.50
(180.59%)
|
|
Buy
|
|
|
Ambuja Cements Ltd (ACL), a part of the global conglomerate LafargeHolcim (63.1% holding in ACL), is one of the leading cement players in India. The company has a cement grinding capacity of 29.7 MTPA with five integrated cement manufacturing plants and clinkerisation capacity of 17.7 MTPA.
|